MedTrace Logo

Transurethral Prostate Resection (TURP) vs. Prostate Artery Embolization (PAE)

NCT05531240 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 104

Last updated 2022-10-03

No results posted yet for this study

Summary

This study focuses on the treatment of benign prostatic hyperplasia which causes lower urinary tract symptoms.

The purpose of the research project is to evaluate PAE in terms of both medical and health economic outcomes. To evaluate whether there are any differences in effect (IPSS), complications, costs and perceived quality of life compared with TUR-P.

Conditions

  • Transurethral Resection of Prostate Syndrome
  • Prostate Hyperplasia
  • Embolization, Therapeutic

Interventions

PROCEDURE

Prostate Artery Embolization

Prostate Artery Embolization (PAE) is performed by experienced interventional radiologists. The method involves catheterization of the prostate vessels superselectively with two to three French microcatheters. PAE is performed with microspheres of 250 to 400 µm in size.

PROCEDURE

Transurethral Prostate Resection (TURP)

Under general/regional anesthesia, a resectoscope is inserted into the urethra that carries an electric metal loop (monopolar or bipolar diathermy) that is used to cut and extract the prostate tissue.

Sponsors & Collaborators

  • Centrallasarettet Västerås

    collaborator OTHER

  • Lasarettet i Enköping

    collaborator OTHER

  • Sormland County Council, Sweden

    collaborator OTHER

  • Helsingborgs Hospital

    collaborator OTHER

  • Uppsala University

    lead OTHER

Principal Investigators

  • Abbas Chabok · CKF Västerås Uppsala university

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
45 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-10-31
Primary Completion
2023-12-31
Completion
2025-12-31

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05531240 on ClinicalTrials.gov